Genflow Biosciences (OTCQB:GENFF) on Wednesday announced that its second European patent application (Application No. 23821586.7, Publication No. EP4630038), titled “SIRT6 Variant for NASH,” has been published in the European Patent Bulletin.
Publication of the patent application in the European Patent Bulletin follows entry into the European phase under the Patent Cooperation Treaty and represents a key milestone in Genflow’s expanding intellectual property portfolio.
Voters in Ireland are going to the polls Friday to elect one of two women as their new president for...
Asian stocks opened higher Friday as a planned meeting between Donald Trump and Xi Jinping eased nerves around trade tensions....
21shares spent years building its crypto franchise outside Wall Street’s orbit. From Zurich, it launched exchange-traded products that gave European...
The Federal Reserve faces an unprecedented challenge as it prepares to set interest rates next week—making its decision with almost no...
Elon Musk stole the show in the final minutes of Tesla’s Wednesday earnings call to label the advisory firms pushing...
New Delhi: The ministry of labour and employment plans to build a unified One Nation Integrated Workforce Architecture that will...
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.
